Trump says Coca-Cola agreed to use ‘real' cane sugar in US products
Currently, Coca-Cola in the US is made with high-fructose corn syrup, whereas cane sugar is utilized in other countries, including Mexico.
A Coca-Cola representative responded by stating they appreciate Trump's enthusiasm and would soon share details on new innovative offerings, without directly confirming the cane sugar agreement.
This move aligns with a broader 'Make America Healthy Again' initiative, which aims to combat chronic illness through wholesome food and environmental toxin elimination.
Kennedy intends for the Food and Drug Administration to phase out the use of petroleum-based synthetic dyes in the nation's food supply, as seen in a recent pledge made by 40 US ice cream producers.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NBC News
19 minutes ago
- NBC News
U.S. program to combat HIV/AIDS survives Trump's latest round of cuts
WASHINGTON — PEPFAR, the popular global HIV/AIDS program credited with saving millions of lives, has been spared from a package of billions of dollars in spending cuts that Congress sent to President Donald Trump early Friday morning to sign into law. The original rescissions package Trump requested called for $400 million in cuts to PEPFAR, the President's Emergency Plan for AIDS Relief, which George W. Bush started in 2003. But in the Senate, Democrats and a handful of Republicans objected to the PEPFAR cuts. Appropriations Committee Chairwoman Susan Collins, R-Maine, said the health program had saved an estimated 26 million lives and allowed nearly 8 million babies to be born healthy to mothers living with HIV. "There are some cuts that I can support, but I'm not going to vote to cut global health programs," Collins told reporters last week. Seeking to tamp down the GOP rebellion, the White House this week agreed to make changes to the package, dropping the PEPFAR cuts to secure GOP votes. 'PEPFAR will not be impacted by the rescissions," White House budget director Russell Vought told reporters after he huddled behind closed doors Tuesday with Senate Republicans. Removing those cuts, Vought said, means the package has 'a good chance of passing.' The rescissions package, which would claw back $9 billion in congressionally approved funding for foreign aid and public broadcasting, narrowly passed the Senate early Thursday on a 51-48 vote. Collins was one of two Republicans to vote against the package, lamenting that the White House had not provided details of the cuts and that 'nobody really knows what program reductions are in it.' The House passed the package of cuts early Friday and Trump has vowed to sign it into law. The White House's original rescissions request sent May 28 detailed that the cuts would target only HIV/AIDS programs that "neither provide life-saving treatment nor support American interests." "This rescission proposal aligns with the Administration's efforts to eliminate wasteful foreign assistance programs," the request said. "Enacting the rescission would restore focus on health and life spending. This best serves the American taxpayer." But even some deficit hawks in the House said they supported the decision to preserve PEPFAR funding. "It's very successful. I think it serves a useful purpose," said conservative Rep. Gary Palmer, R-Ala., who voted for the rescissions package. Rep. Tim Burchett, R-Tenn., a member of the Foreign Affairs Committee who also supported the package, said, "It's half the money we've given to Ukraine, and it's saved 25 million lives." Senate Minority Leader Chuck Schumer, D-N.Y., slammed the legislation and said the PEPFAR-related changes were insufficient. 'Cuts to foreign aid will make Americans less safe. It will empower our adversaries,' he said. 'The changes Republicans say they've made to PEPFAR are not enough, and nobody's fooled by small tweaks to this package.' Some advocates were relieved by the removal of PEPFAR cuts but disappointed with the overall package. 'It is always good news when lawmakers prioritize children, especially children who are orphaned or vulnerable to HIV and AIDS. But the larger trend here is not hopeful," said Bruce Lesley, the president of First Focus Campaign for Children. 'While a few senators persuaded their colleagues to preserve funding for these children in this case," he said in a statement, "the Senate's overall decision to hand $9 billion back to the President suggests that what the legislature does actually doesn't matter.'
The Independent
3 hours ago
- The Independent
Gastrointestinal cancer is the fastest-growing early-onset cancer in the US, research shows
A new review has identified a dramatic increase in early-onset gastrointestinal cancers among people under 50 in the US. Colorectal cancer was the most common early-onset gastrointestinal cancer in 2022, with over 20,800 diagnoses. The rise in these cancers is largely attributed to modifiable risk factors, including obesity, poor diet, inactive lifestyles, smoking, and alcohol consumption. The prognosis for early-onset gastrointestinal cancers is similar to or worse than later-onset cases, underscoring the need for improved prevention and early detection. The American Cancer Society now recommends regular colorectal cancer screening from the age of 45, a reduction from the previous age of 50. Dramatic rise in gastrointestinal cancers in people under 50
The Independent
5 hours ago
- The Independent
Dramatic rise in gastrointestinal cancers in people under 50
There has been a dramatic rise in gastrointestinal cancers in people under the age of 50, according to a new review. Gastrointestinal cancers, such as colorectal cancer and pancreatic cancer, 'represent the most rapidly increasing early-onset cancer in the US,' researchers wrote in a review published in The Journal of the American Medical Association (JAMA) Thursday. Colorectal cancer, which develops in the colon or rectum, was the most common among early-onset gastrointestinal cancers in the U.S. in 2022, with just over 20,800 people diagnosed. There were 2,689 diagnoses of Gastric cancer, which develops in the stomach lining, that year, followed by 2,657 diagnoses of pancreatic cancer and 875 diagnoses of esophageal cancer. Most early-onset gastrointestinal cancers are linked to risk factors that could be changed, such as obesity, poor-quality diet, and a somewhat inactive lifestyle. Smoking cigarettes and drinking alcohol are other risk factors. 'It's really what people were doing or exposed to when they were infants, children, adolescents that is probably contributing to their risk of developing cancer as a young adult,' Dr. Kimmie Ng, the review's co-author and director of the Young-Onset Colorectal Cancer Center at Dana-Farber Cancer Institute, told NBC News. There are also risk factors that patients don't have control over such as family history and hereditary syndromes. People with early-onset colorectal cancer could have inflammatory bowel disease. Researchers wrote in the review: 'The prognosis for patients with early-onset GI cancers is similar to or worse than that for patients with later-onset GI cancers, highlighting the need for improved methods of prevention and early detection.' The American Cancer Society recommends people at average risk of colorectal cancer start regular screening at the age of 45. Before 2018, the ACS recommended screenings start at the age of 50. 'It never used to happen in this age group, and now a very significant rise in 20-, 30- and 40-year-olds are getting colon cancer,' Dr. John Marshall, chief medical consultant at the nonprofit Colorectal Cancer Alliance, who was not involved in the review, told NBC News. It's still unclear why young patients with gastrointestinal cancers could have worse survival rates than older patients. 'My personal feeling is that it's because we're finding them at a more advanced stage, because people don't really think of colon or other GI cancers when they see a young person with these nonspecific complaints,' Dr. Howard Hochster, director of gastrointestinal oncology at Rutgers Cancer Institute and RWJBarnabas Health in New Jersey, who was not involved in the review, told NBC News. But Ng said even when taking the stage of cancer into account, young patients still seem to have worse survival rates, and questioned whether there's a biological reason.
